Letters Section Editor: Robert M. Golub,
MD, Senior Editor.
To the Editor: Dr Murthy and colleagues1 report that cancer trial participation is low.
Only 1.8% of white cancer patients enroll in therapeutic nonsurgical National
Cancer Institute clinical trials. Among racial minorities, women, and elderly
persons, even fewer enroll. The low inclusion rates together with an apparent
selection bias for younger white people may pose a serious problem with generalizability.
Bjarnason NH. Disparities in Participation in Cancer Clinical Trials. JAMA. 2004;292(8):922. doi:10.1001/jama.292.8.922-a